Wael Adhami and Roy Albiani, both with Johnson & Johnson’s Global Brand Protection team, take us through the startling discovery of a counterfeit implantable medical device – a widely used topical absorbable hemostat which controls bleeding during surgery. The genuine of this product, SURGICEL, is estimated to have been used in 150 million surgical procedures worldwide. Wael and Roy reveal the initial discovery, followed by the launching of global investigations, and coordinated pursuits of those responsible for the crime, which included involvement of a network of distributors and gray market sources. Wael and Roy then share how this case has changed how they each approach protection of the Johnson and Johnson family of brands.